Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.52 USD | -2.63% | +1.18% | +42.70% |
05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.70% | 1.61B | |
+3.33% | 106B | |
+7.02% | 23.47B | |
-14.61% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.10% | 16.78B | |
+5.57% | 14.41B | |
+37.41% | 12.86B | |
+328.40% | 8.78B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Stifel Adjusts Price Target on Kura Oncology to $25 From $24, Maintains Buy Rating